Marcel Zughaib is a Cardiology physician affiliated with Henry Ford Health. OpenAlex indexes 111 publications with 1,748 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22250 Providence Dr.
#705
Southfield, MI 48075
Telephone
248-552-9858Registry record last updated 13 Jan 2014.
Clinical trials
- Accelerated Ambulation After Vascular Access Closure Device
Sponsor: Henry Ford Health System
Overall officialCompletedNCT03142126
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202510 payments
- ABIOMEDProgram year20252 payments
- Kestra Medical Technology Services, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.5%Statin19.3%Atorvastatin Calcium66%Rosuvastatin Calcium20%Simvastatin7%Pravastatin Sodium6%Lovastatin1%Part D<11 patientsBeta blocker18.9%Carvedilol68%Metoprolol Succinate21%Metoprolol Tartrate6%Atenolol2%Nebivolol Hcl2%Sotalol1%Part D<11 patients+ 16 more classes in this area
Blood & clotting
13.5%Factor Xa inhibitor7.1%Xarelto76%Eliquis24%Part D≥120 patientsP2Y12 inhibitor5.4%Clopidogrel85%Prasugrel Hcl15%Part D≥116 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1%SGLT2 inhibitor0.5%Farxiga55%Jardiance45%Part D<11 patientsPotassium supplement0.5%Potassium Chloride100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical and Electrophysiological Outcomes of Left Bundle Area Pacing Compared to Biventricular Pacing: An Updated Meta-analysis
Journal of Innovations in Cardiac Rhythm Management
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Philip, MD
Henry Ford Health
David Lanfear, MD
Henry Ford Health
Marvin Eng, MD
Henry Ford Health
Karthikeyan Ananthasubramaniam, MD
Henry Ford Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”